Evgeny Kulesskiy

2.4k citations

25 papers · 1.2k indexed · h-index 19

Developmental Neuroscience top 10%
Cell Biology top 10%
- Proteoglycans and glycosaminoglycans research 4
Cancer Research
- Cancer Genomics and Diagnostics 3
Molecular Biology
- Glycosylation and Glycoproteins Research 3
Cellular and Molecular Neuroscience top 10%
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 3
Computational Theory and Mathematics
- Computational Drug Discovery Methods 3
Genetics
- Glioma Diagnosis and Treatment 3
Biomedical Engineering
- Innovative Microfluidic and Catalytic Techniques Innovation 2
- Microfluidic and Capillary Electrophoresis Applications 2

Co-authors: Krister Wennerberg Tero Aittokallio Heikki Rauvala Sarka Tumova Jani Saarela Bhagwan Yadav Laura Turunen Anni Hienola
Cited by: Developmental Neuroscience Cell Biology Cancer Research
Journals: Scientific Reports (3 papers)The Journal of Cell Biology (2 papers)Cancer Research (2 papers)
Partner nations: Finland United States Norway

In The Last Decade

Evgeny Kulesskiy

25 papers receiving 1.2k citations

Peers

Countries citing papers authored by Evgeny Kulesskiy

Since Specialization

Citations

This map shows the geographic impact of Evgeny Kulesskiy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgeny Kulesskiy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgeny Kulesskiy more than expected).

Fields of papers citing papers by Evgeny Kulesskiy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evgeny Kulesskiy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgeny Kulesskiy. The network helps show where Evgeny Kulesskiy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Evgeny Kulesskiy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Evgeny Kulesskiy Line = papers co-authored together Evgeny Kulesskiy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome Translational Oncology ·Erlend Skaga,Evgeny Kulesskiy,Swapnil Potdar,Ioannis Panagopoulos,諭保田,Iver A. Langmoen,Cecilie Sandberg,Einar Osland Vik-Mo	2022	3
2	Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments Briefings in Bioinformatics ·Ziaurrehman Tanoli,Jehad Aldahdooh,فاطمه ابراهیمی فینی,Yinyin Wang,Jessica Minahan,Maddalena Fratelli,Cheng Fang,Marián Hajdúch,Florence Biétrix,Philip Gribbon,Andrea Zaliani,Matthew D. Hall,Min Shen,Kyle R. Brimacombe,Evgeny Kulesskiy,Jani Saarela,Krister Wennerberg,Markus Vähä‐Koskela,Jing Tang	2021	8
3	Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1 Journal of Biological Chemistry ·Otto Kauko,Susumu Y. Imanishi,Evgeny Kulesskiy,Laxman Yetukuri,Teemu D. Laajala,J. Jesús de Bustos,Karolina Pavic,Anna Aakula,Christian Rupp,KN Jeon,Pekka Haapaniemi,Shameem Ahmad Rather,Bhagwan Yadav,Hartmut Ulrich,Valerie R.C. Allusson,Garry L. Corthals,Jüri Reimand,Krister Wennerberg,Tero Aittokallio,Jukka Westermarck	2020	45
4	High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro Biomolecules ·Laura Torrente,J Belzner,Joonas Junttila,Jean A. Quinn,Teresa Bueno-Carrasco,Andrea Grilli,Laura Casares,Ying Zhang,Evgeny Kulesskiy,Jani Saarela,Silvio Bicciato,Joanne Edwards,Albena T. Dinkova‐Kostova,Laureano de la Vega	2020	32
5	Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma BMC Cancer ·Erlend Skaga,Evgeny Kulesskiy,Helena Simidu Masumi,Cecilie Sandberg,Swapnil Potdar,Aija Kyttälä,Iver A. Langmoen,Aki Laakso,Emília Gaál‐Paavola,Markus Perola,Krister Wennerberg,Einar Osland Vik-Mo	2019	55
6	Anagrelide for Gastrointestinal Stromal Tumor Clinical Cancer Research ·Mbursa J. Nayagawa,Yemarshet K. Gebreyohannes,Agnieszka Woźniak,C. Costaguta,Olli Tynninen,F Molina,Alejandra Cervera,Salla Keskitalo,Astrid Murumägi,Evgeny Kulesskiy,Shuguang Yuan,Krister Wennerberg,Markku Varjosalo,Pirjo Laakkonen,Rainer Lehtonen,Sampsa Hautaniemi,Olli Kallioniemi,Patrick Schöffski,Harri Sihto,Heikki Joensuu	2018	19
7	Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy Molecular Cancer Therapeutics ·Masayuki Kon,Aulya Fazira,Riku Louhimo,Bhagwan Yadav,Astrid Murumägi,Evgeny Kulesskiy,Huifen Xin,Harri Sihto,Reidar Grénman,Stina Syrjänen,Olli Kallioniemi,Tero Aittokallio,Krister Wennerberg,Heikki Joensuu,Outi Monni	2018	32
8	Methods for High-throughput Drug Combination Screening and Synergy Scoring Methods in molecular biology ·Liye He,Evgeny Kulesskiy,Jani Saarela,Laura Turunen,Krister Wennerberg,Tero Aittokallio,Jing Tang	2018	126
9	PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells Science Translational Medicine ·Otto Kauko,Caitlin M. O’Connor,Evgeny Kulesskiy,Jaya Sangodkar,Anna Aakula,Sudeh Izadmehr,Laxman Yetukuri,Bhagwan Yadav,Artur Padzik,Teemu D. Laajala,Pekka Haapaniemi,Majid Momeny,Valerie R.C. Allusson,Michael Ohlmeyer,Tero Aittokallio,Krister Wennerberg,Goutham Narla,Jukka Westermarck	2018	99
10	Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells Gynecologic Oncology ·M. Zapert,Noora Andersson,Bhagwan Yadav,Anniina Färkkilä,Evgeny Kulesskiy,Matti Kankainen,Jing Tang,Ralf Bützow,Annika Riska,Arto Leminen,Markku Heikinheimo,Olli Kallioniemi,Leila Unkila‐Kallio,Krister Wennerberg,Tero Aittokallio,Mikko Anttonen	2017	27
11	Abstract 5560: Systemic map of protein phosphatase 2A (PP2A)-regulated phosphotargets and drug responses in cancer cells Cancer Research ·Otto Kauko,Susumu Y. Imanishi,Evgeny Kulesskiy,Teemu D. Laajala,Ю.Н. Зборищук,Artur Padzik,KN Jeon,Pekka Haapaniemi,Itumeleng Eskia Mekwa,Hartmut Ulrich,Valerie R.C. Allusson,Garry L. Corthals,Krister Wennerberg,Tero Aittokallio,Jukka Westermarck	2017	1
12	HMGB4 is expressed by neuronal cells and affects the expression of genes involved in neural differentiation Scientific Reports ·Ari Rouhiainen,Xiang Zhao,Päivi Vanttola,Kui Qian,Evgeny Kulesskiy,Juha Kuja‐Panula,В. И. Дорофеев,Mikaela Grönholm,Emmanual Unni,Marvin L. Meistrich,Li Tian,Petri Auvinen,Heikki Rauvala	2016	18
13	Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages Molecular & Cellular Proteomics ·Sandra Söderholm,Denis E. Kainov,Tiina Öhman,Oxana V. Denisova,Bert Schepens,Evgeny Kulesskiy,Susumu Y. Imanishi,Garry L. Corthals,Petteri Hintsanen,Tero Aittokallio,Xavier Saelens,Sampsa Matikainen,Tuula A. Nyman	2016	57
14	HB-GAM (pleiotrophin) reverses inhibition of neural regeneration by the CNS extracellular matrix Scientific Reports ·Mikhail Paveliev,Keith K. Fenrich,Mikhail Kislin,Juha Kuja‐Panula,Evgeny Kulesskiy,Markku Varjosalo,Tommi Kajander,Hardeana Budi Pawestri,Л. М. Саптарова,Leonard Khiroug,Natalia Kulesskaya,Geneviève Rougon,Heikki Rauvala	2016	41
15	Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies Scientific Reports ·Bhagwan Yadav,Tea Pemovska,Agnieszka Szwajda,Evgeny Kulesskiy,Mika Kontro,Riikka Karjalainen,Muntasir Mamun Majumder,Disha Malani,Astrid Murumägi,Jonathan C. Knowles,Kimmo Porkka,Caroline A. Heckman,Olli Kallioniemi,Krister Wennerberg,Tero Aittokallio	2014	214
16	A personalised medicine drug sensitivity and resistance testing platform and utilisation of acoustic droplet ejection at the Institute for Molecular Medicine Finland Jani Saarela,Evgeny Kulesskiy,E.C. Obuah W. Ikonwa,Tea Pemovska,Vilja Pietiäinen,Swapnil Potdar,C Peterson,Laura Turunen,Päivi Östling,Krister Wennerberg	2014	3
17	Transmembrane Prostatic Acid Phosphatase (TMPAP) Interacts with Snapin and Deficient Mice Develop Prostate Adenocarcinoma PLoS ONE ·Ileana B. Quintero,Annakaisa M. Herrala,Andrian Ersa Maulana,Anitta E. Pulkka,Sampsa Hautaniemi,Kristian Ovaska,Evgeny Pryazhnikov,Evgeny Kulesskiy,Maija Ruuth,Ylermi Soini,Raija Sormunen,Marlon Montes Padilla,Pirkko Vihko	2013	29
18	Antifungal Application of Nonantifungal Drugs Antimicrobial Agents and Chemotherapy ·Marios Stylianou,Evgeny Kulesskiy,José Pedro Lopes,Margareta Granlund,Krister Wennerberg,Constantin F. Urban	2013	59
19	N-syndecan deficiency impairs neural migration in brain The Journal of Cell Biology ·Anni Hienola,Sarka Tumova,Evgeny Kulesskiy,Heikki Rauvala	2006	86
20	Expression of the recombinant antibacterial peptide sarcotoxin IA in Escherichia coli cells Protein Expression and Purification ·Harvey Nissley,Evgeny Kulesskiy,Alexander V. Yakhnin,P. Corcia,Leonid M. Vinokurov	2003	65

About Evgeny Kulesskiy

Evgeny Kulesskiy is a scholar working on Reproductive Medicine, Cell Biology, Genetics, Otorhinolaryngology and Molecular Biology, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer Mechanisms and Therapy (3 papers), Computational Drug Discovery Methods (3 papers), Glioma Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers) and Microfluidic and Capillary Electrophoresis Applications (2 papers). The work is most often cited by research in Developmental Neuroscience (72 citations), Cell Biology (173 citations), Cancer Research (154 citations), Molecular Biology (687 citations) and Cellular and Molecular Neuroscience (170 citations). Evgeny Kulesskiy has collaborated with scholars based in Finland, United States and Norway. Frequent co-authors include Krister Wennerberg, Tero Aittokallio, Heikki Rauvala, Sarka Tumova, Jani Saarela, Bhagwan Yadav, Laura Turunen, Anni Hienola, Jing Tang and Olli Kallioniemi. Their work appears in journals such as Scientific Reports, The Journal of Cell Biology, Cancer Research, Molecular Cancer Therapeutics and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact